Literature DB >> 7641907

An estimate of the cost of in vitro fertilization services in the United States in 1995.

J A Collins1, M Bustillo, R D Visscher, L D Lawrence.   

Abstract

OBJECTIVE: To estimate the cost of adding IVF treatment to a standard health care benefits package. In vitro fertilization cost is defined as the average charge for a single cycle of treatment in an existing IVF program.
DESIGN: Cost analysis.
SETTING: Two hundred sixty IVF centers active in the United States in 1993. MAIN OUTCOME MEASURES: In vitro fertilization utilization and outcomes for 1993 were estimated from data in an existing registry. In vitro fertilization charges were determined from a 1993 survey of IVF clinics. The resulting expenditures for benefits and premiums were projected to 1995 together with the additional cost if utilization were to increase by 300% or 500%.
RESULTS: In the United States in 1993 there were 31,718 IVF cycles for which the average charge was $6,233, leading to a total expenditure of approximately $197.70 million for IVF services in 1993. The projected cost of adding IVF services to a typical employer health plan in 1995 would be $2.79 per annum and the premium would be $3.14. Benefits and premium costs for a 300% utilization increase were $8.37 and $9.41, respectively, and for a 500% increase, $13.95 and $15.69, respectively.
CONCLUSIONS: The cost of IVF services would be a minute fraction of the annual cost of a typical family benefits program ($3,393). Savings from reduced utilization of alternative treatments would offset a portion of this increase. Increases in utilization rates should be controlled by clinical criteria.

Entities:  

Mesh:

Year:  1995        PMID: 7641907     DOI: 10.1016/s0015-0282(16)57789-9

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

Review 1.  Preimplantation genetic screening: does it help or hinder IVF treatment and what is the role of the embryo?

Authors:  Kim Dao Ly; Ashok Agarwal; Zsolt Peter Nagy
Journal:  J Assist Reprod Genet       Date:  2011-07-09       Impact factor: 3.412

2.  Costs of infertility treatment: results from an 18-month prospective cohort study.

Authors:  Patricia Katz; Jonathan Showstack; James F Smith; Robert D Nachtigall; Susan G Millstein; Holly Wing; Michael L Eisenberg; Lauri A Pasch; Mary S Croughan; Nancy Adler
Journal:  Fertil Steril       Date:  2010-12-04       Impact factor: 7.329

3.  The influence of supernumerary embryos on the clinical outcome of IVF cycles.

Authors:  O Salha; T Dada; S Levett; V Allgar; V Sharma
Journal:  J Assist Reprod Genet       Date:  2000-07       Impact factor: 3.412

4.  Factors influencing patients' decision not to repeat IVF.

Authors:  J Goldfarb; C Austin; H Lisbona; R Loret de Mola; B Peskin; S Stewart
Journal:  J Assist Reprod Genet       Date:  1997-08       Impact factor: 3.412

5.  Analytical optimal controls for the state constrained addition and removal of cryoprotective agents.

Authors:  James D Benson; Carmen C Chicone; John K Critser
Journal:  Bull Math Biol       Date:  2012-04-20       Impact factor: 1.758

6.  Quantifying the biomechanics of conception: L-selectin-mediated blastocyst implantation mechanics with engineered "trophospheres".

Authors:  Robert W Yucha; Monika Jost; Dianne Rothstein; Noreen Robertson; Michele S Marcolongo
Journal:  Tissue Eng Part A       Date:  2013-10-12       Impact factor: 3.845

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.